Biochemical and Genetic Markers in Neurological Trauma and Tumors: Review Article

References (93)

1. 1 The 2007 WHO Classification of Tumours of the Central Nervous System [DOI]
2. 2 The Emerging Hallmarks of Cancer Metabolism [DOI]
3. 3 An Integrated Genomic Analysis of Human Glioblastoma Multiforme [DOI]
4. 4 Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks [DOI]
5. 5 IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype [DOI]
6. 6 Position Statement: Definition of Traumatic Brain Injury [DOI]
7. 7 The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases [DOI]
8. 8 Role of Oxidative Stress in Parkinson's Disease [DOI]
9. 9 Glioma Subclassifications and Their Clinical Significance [DOI]
10. 10 Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases [DOI]
11. 11 Incidence of Spinal Cord Injury Worldwide: A Systematic Review [DOI]
12. 12 Epidemiology of Brain Tumors [DOI]
13. 13 Cytosolic NADP+-dependent isocitrate dehydrogenase status modulates oxidative damage to cells [DOI]
14. 14 Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review [DOI]
15. 15 Journal Of Trauma And Acute Care Surgery [DOI]
16. 16 Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases [DOI]
17. 17 Caring for the brain tumor patient: Family caregiver burden and unmet needs [DOI]
18. 18 Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction [DOI]
19. 19 Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries [DOI]
20. 20 What is the function of neuroglobin? [DOI]
21. 21 2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling [DOI]
22. 22 Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007 [DOI]
23. 23 Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents [DOI]
24. 24 Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration [DOI]
25. 25 Glial Fibrillary Acidic Protein is Highly Correlated With Brain Injury [DOI]
26. 26 The Head Injury Severity Scale (HISS): A practical classification of closed-head injury [DOI]
27. 27 Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons [DOI]
28. 28 Neuroglobin: From structure to function in health and disease [DOI]
29. 29 Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries [DOI]
30. 30 The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis [DOI]
31. 31 Oncometabolites d - and l -2-Hydroxyglutarate Inhibit the AlkB Family DNA Repair Enzymes under Physiological Conditions [DOI]
32. 32 2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter [DOI]
33. 33 Protection by Neuroglobin Expression in Brain Pathologies [DOI]
34. 34 An Antiapoptotic Neuroprotective Role for Neuroglobin [DOI]
35. 35 A protein with kinase and phosphatase activities involved in regulation of tricarboxylic acid cycle [DOI]
36. 36 Allosteric Motions in Structures of Yeast NAD+-specific Isocitrate Dehydrogenase [DOI]
37. 37 Structural and mechanistic insights into the bifunctional enzyme isocitrate dehydrogenase kinase/phosphatase AceK [DOI]
38. 38 Proteomic and histochemical analysis of proteins involved in the dying-back-type of axonal degeneration in the gracile axonal dystrophy (gad) mouse [DOI]
39. 39 Homozygous mutation, p.Pro304His, in IDH3A, encoding isocitrate dehydrogenase subunit is associated with severe encephalopathy in infancy [DOI]
40. 40 Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury [DOI]
41. 41 Management of severe traumatic brain injury [DOI]
42. 42 Homologous Binding Sites in Yeast Isocitrate Dehydrogenase for Cofactor (NAD+) and Allosteric Activator (AMP) [DOI]
43. 43 Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation [DOI]
44. 44 Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors [DOI]
45. 45 The expression of neuroglobin in astrocytoma [DOI]
46. 46 Epidemiology of moderate and severe traumatic brain injury in Cairo University Hospital in 2010 [DOI]
47. 47 Neuroglobin and Cytoglobin:Two New Members of Globin Family
48. 48 The Proceedings of the National Academy of Sciences [DOI]
49. 49 D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function [DOI]
50. 50 IDH Mutation, Competitive Inhibition of FTO, and RNA Methylation [DOI]
51. 51 CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 [DOI]
52. 52 R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling [DOI]
53. 53 Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [DOI]
54. 54 Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury [DOI]
55. 55 The implications of IDH mutations for cancer development and therapy [DOI]
56. 56 Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma [DOI]
57. 57 A Manual for the Glasgow Outcome Scale-Extended Interview [DOI]
58. 58 Epidemiology of worldwide spinal cord injury: a literature review [DOI]
59. 59 Oncometabolites suppress DNA repair by disrupting local chromatin signalling [DOI]
60. 60 Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease [DOI]
61. 61 2016 World Health Organization Classification of Central Nervous System Tumors [DOI]
62. 62 A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016 [DOI]
63. 63 Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury [DOI]
64. 64 IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications? [DOI]
65. 65 Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications [DOI]
66. 66 Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities [DOI]
67. 67 Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315 [DOI]
68. 68 National Cancer Institute of Canada Clinical Trials Group [DOI]
69. 69 Neuroglobin mediates neuroprotection of hypoxic postconditioning against transient global cerebral ischemia in rats through preserving the activity of Na+/K+ ATPases [DOI]
70. 70 Ubiquitin C‐Terminal Hydrolase L1: Biochemical and Cellular Characterization of a Covalent Cyanopyrrolidine‐Based Inhibitor [DOI]
71. 71 Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase [DOI]
72. 72 The role of globins in cardiovascular physiology [DOI]
73. 73 Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells [DOI]
74. 74 Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological induction [DOI]
75. 75 Role of Isocitrate Dehydrogenase 2 on DNA Hydroxymethylation in Human Airway Smooth Muscle Cells [DOI]
76. 76 Accuracy of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) score as an objective assessment tool for predicting return-to-work status after head and neck cancer in male survivors [DOI]
77. 77 Fluoxetine-induced androgenic failure impairs the seminiferous tubules integrity and increases ubiquitin carboxyl-terminal hydrolase L1 (UCHL1): Possible androgenic control of UCHL1 in germ cell death? [DOI]
78. 78 Serum periostin concentrations and outcomes after severe traumatic brain injury [DOI]
79. 79 UCHL1 regulates muscle fibers and mTORC1 activity in skeletal muscle [DOI]
80. 80 Development of Ubiquitin Variants with Selectivity for Ubiquitin C‑Terminal Hydrolase Deubiquitinases [DOI]
81. 81 Non-Methylation-Linked Mechanism of REST-Induced Neuroglobin Expression Impacts Mitochondrial Phenotypes in a Mouse Model of Amyotrophic Lateral Sclerosis [DOI]
82. 82 Evolution of a key enzyme of aerobic metabolism reveals Proterozoic functional subunit duplication events and an ancient origin of animals [DOI]
83. 83 Characterization of metal binding of bifunctional kinase/phosphatase AceK and implication in activity modulation [DOI]
84. 84 Classification of Head Injury [DOI]
85. 85 Translation, validity, and reliability of disability rating scale in Iranian patients with traumatic brain injury [DOI]
86. 86 Serum concentration of ubiquitin c-terminal hydrolase-L1 in detecting severity of traumatic brain injury [DOI]
87. 87 Cross-sectional imaging of head trauma: a retrospective analysis of the incidence, and imaging findings of traumatic brain injury in King Fahad Hospital, Al-Ahsa, Saudi Arabia [DOI]
88. 88 International Journal of Molecular Sciences [DOI]
89. 89 Philosophical Transactions of the Royal Society B: biological sciences [DOI]
90. 90 Oxidative Medicine and Cellular Longevity [DOI]
91. 91 Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study. [DOI]
92. 92 Journal of Neurosciences in Rural Practice [DOI]
93. 93 Ependymoma, RELA Fusion-Positive [DOI]

Cited by 0

No indexed citations yet.